What information do public organizations provide to Belgian women on primary prevention of breast cancer?

European Journal of Cancer Prevention

Volumn 19, Issue 1, 2010, Pages 68-70

  Liebens, Fabienne ^a   Aimont, Mireille ^a   Beauraing, Françoise ^a   Carly, Birgit ^a   Cusumano, Pino ^a   Rozenberg, Serge ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Breast cancer; Information; Prevention; Public education; Risk reductions

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BELGIUM; BENIGN TUMOR; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; ETHNICITY; EXERCISE; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HEALTH SERVICE; HORMONAL THERAPY; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; OBESITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION;

ADULT; AGED; BELGIUM; BREAST NEOPLASMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; MIDDLE AGED; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PRIMARY PREVENTION; PUBLIC HEALTH ADMINISTRATION; PUBLIC SECTOR; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 75149138816     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32830c8dba     Document Type: Article

References (16)

1. Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, et al. (2007). Breast cancer risk reduction: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 5:676-701.
2. Bluming AZ, Elfenbein GJ, Kliewer EV, Demers AA, Nugent ZJ, Zahl PH, et al. (2007). A decline in breast-cancer incidence. N Engl J Med 357:509-513.
3. Boyle P, Autier P, Barteline H, Baselga J, Boffetta P, Burn J, et al. (2003). European code against cancer and scientific justification: third version. Ann Oncol 14:973-1005.
4. Coulter A (2001). Patient-centered decision making: empowering women to make informed choices. Women's Health Issues 11:325-330.
5. Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P. (2003). Overview of the main outcomes in breast-cancer prevention trials. Lancet 3 61:296-300.
6. De Vries H, Mesters I, van de Steeg H, Honing C. (2005). The general public's information needs and perceptions regarding hereditary cancer: an application of the Integrated Change Model. Patient Educ Couns 56:154-165.
7. Fasching PA, von Minckwitz G, Fischer T, Kaufmann M, Schultz-Zehden B, Beck H, et al. (2007). The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs. Breast Cancer Res Treat 101:95-104.
8. Giordano L, Rowinski M, Gaudenzi G, Segnan N. (2005). What information do breast cancer screening programmes provide to Italian women? Eur J Public Health 15:66-69.
9. Kiluk JV, Acs G, Hoover SJ (2007). High-risk Benign breast lesions: current strategies in management. Cancer Control 14:321-329.
10. McTiernan A (2003). Behavioral risk factors in breast cancer: can risk be modified. Oncologist 8:326-334.
11. Pohls UG, Fasching PA, Beck H, Kaufmann M, Kiechle M, von Minckwitz G, et al. (2005). Demographic and psychosocial factors associated with risk perception for breast cancer. Oncol Rep 14:1605-1613.
12. Ravdin P, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. (2007). The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674.
13. Smith AJ (1995). Information leaflets. J Med Screening 2:3-4.
14. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. J Am Med Assoc 295:2727-2741. Erratum in: JAMA 2006; 296:2926.
15. Webster P, Austoker J (2007). Does the English breast screening programme's information leaflet improve women's knowledge about mammography screening? A before and after questionnaire survey. J Public Health 29: 1 73-177.
16. Willey SC, Cocilovo C (2007). Screening and follow up of the patient at high risk for breast cancer. Obstet Gynecol 110:1404-1416.